There’s something magical about stepping into a place where time doesn’t just stand still—it’s actually for sale. Collinsville Antiques Co in New Hartford, Connecticut isn’t just an antique store; ...

Cumberland Pharmaceuticals Inc. , a specialty pharmaceutical company focused on developing new products for rare diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted ...

Good day, everyone, and welcome to Pfizer's Fourth Quarter 2025 Earnings Conference Call. Today's call is being recorded. At ...

Arbutus Biotech (ABUS) heads to a key March Moderna LNP patent trial as imdusiran HBV milestones drive value—get the latest ...

The market for TIGIT inhibitors is expected to grow significantly in the coming years. This is due to the increasing number ...

The market for TIGIT inhibitors is expected to grow significantly in the coming years. This is due to the increasing number of patients who are being diagnosed with NSCLC, RCC, colorectal cancer ...

Dr. James McCaffrey presents a complete end-to-end demonstration of linear regression with pseudo-inverse training implemented using JavaScript. Compared to other training techniques, such as ...

The deal underscores a broader shift in autoimmune drug development toward therapies that aim to reprogram disease-driving ...

The DUB inhibitors market is poised for steady growth, driven by rising interest in targeted protein degradation and novel oncology therapeutics. The ...

The DUB inhibitors market is poised for steady growth, driven by rising interest in targeted protein degradation and novel oncology therapeutics. The growing prevalence of cancer and neurodegenerative ...

After that, Pascal will provide a little more color on our fourth quarter performance, planned changes to our segment reporting next quarter, and key drivers of our financial guidance through 2028.